Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Screening mammography for breast cancer gets better all the time, finding very small cancers that may be most amenable to cure. Also detected more often are cancers that would never have caused a problem but are treated anyway, so-called overdiagnosis. …
Podcast: Download (Duration: 1:04 — 1.5MB)
Subscribe: RSS
Colonoscopy is considered by many to be the gold standard for screening for colorectal cancer. Kathy Bull Henry, a colorectal cancer expert at Johns Hopkins, says there are other considerations. Bull Henry: Screening tests have to be acceptable. I think …
What are the types of screening for colorectal cancer? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Black Americans have higher rates of colorectal cancer than white Americans, the nation’s cancer report card finds. While researchers are trying to discern why this is so, Kathy Bull Henry, a colorectal cancer expert at Johns Hopkins, says we can …
Podcast: Download (Duration: 1:01 — 1.4MB)
Subscribe: RSS
Finding cancers very early is the goal of screening, but for colorectal cancer, or CRC, rates of screening are disappointingly low in some places. That’s according to Kathy Bull Henry, a colorectal cancer expert at Johns Hopkins. Bull Henry: In …
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
Colorectal cancer cases are declining overall in the US, the most recent cancer report card found, but unfortunately are rising in younger people. The report also finds that disparities in cancer rates among different racial groups have been persisting. Kathy …
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
The nation’s cancer report card shows that while overall rates of colorectal cancer are declining, among younger people they are increasing. Kathy Bull Henry, a colorectal cancer expert at Johns Hopkins, says especially in those who are younger, symptoms can …
Colorectal cancer incidence is increasing among younger people, Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:08 — 1.6MB)
Subscribe: RSS
Biosimilars are a class of drugs that are essentially generic versions of others used to treat cancer, and if you’re undergoing cancer treatment you may have concerns about whether they’re really as effective. Rest easy, says William Nelson, director of …
Certain kinds of cancer drugs do appear equivalent, Elizabeth Tracey reports Read more »
